These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 2507568)

  • 1. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
    McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.
    Welt CK; Martin KA; Taylor AE; Lambert-Messerlian GM; Crowley WF; Smith JA; Schoenfeld DA; Hall JE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2645-52. PubMed ID: 9253348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition.
    le Nestour E; Marraoui J; Lahlou N; Roger M; de Ziegler D; Bouchard P
    J Clin Endocrinol Metab; 1993 Aug; 77(2):439-42. PubMed ID: 8345049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J; Banah M; McCloud P; Hee J; Burger H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
    Hall JE; Schoenfeld DA; Martin KA; Crowley WF
    J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
    Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating bioactive follicle stimulating hormone and immunoreactive inhibin levels during the normal human menstrual cycle.
    Reddi K; Wickings EJ; McNeilly AS; Baird DT; Hillier SG
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):547-57. PubMed ID: 2121399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids.
    Burger HG; Hee JP; Mamers P; Bangah M; Zissimos M; McCloud PI
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):771-7. PubMed ID: 7889613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
    Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle.
    Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ
    J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
    Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC
    J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.